EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Registration of essential medicines in Kenya, Tanzania and Uganda: a retrospective analysis

A Green, R Lyus iD, M Ocan, A M Pollock iD, P Brhlikova iD

Journal of the Royal Society of Medicine · 2023

DOI: 10.1177/01410768231181263 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Royal Society of Medicine, 2023. Verfasst von A Green und 4 weiteren Autor:innen. Beteiligte Einrichtung: Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne NE2 4AX, UK. Hauptthemen laut MEDLINE: Drugs, Essential. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To audit national drug registers (NDRs) in Kenya, United Republic of Tanzania and Uganda with respect to national Essential Medicine Lists (EMLs) and to conduct an analysis of highly registered products including a sub-analysis of highly registered antimicrobial products.

Design

Retrospective analysis of registration of essential medicines and medicinal products on NDRs as of February 2018.

Setting

Not applicable.

Participants

None. Main outcome measures Registration status of essential medicines by country, essential medicine status of registered products by country and medicines with more than 50 registrations across all three countries.

Results

A high proportion of essential medicines are not registered: Kenya 28% (175/632), United Republic of Tanzania 50% (400/797) and Uganda 40% (266/663). Of registered products on the NDRs, more than half are not essential: Kenya 71% (4350/6151), United Republic of Tanzania 64% (2278/3590) and Uganda 58% (2268/3896). When the three NDRs were combined, there were 42 medicines with over 50 registered products, accounting for 30% (4153/13637) of products, many of which were non-essential.

Conclusions

Non-registration of essential medicines is a barrier to availability. Over-registration of medicines, particularly non-essential medicines, diverts regulatory resources towards registering non-priority and, sometimes, clinically sub-optimal medicines. The East African Community Medicines Registration Harmonization Project has the potential to improve access to key medicines if registration of essential medicines is prioritised and registration of non-essential medicines is restricted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, EssentialHumansKenyaUgandaTanzaniaRetrospective Studies

Stichwörter der Autor:innen

Clinicalmedicines regulationnon-clinicalpharmacology and therapeuticspublic health

Substanzen

Drugs, Essential

Autor:innen und Institutionen

  • Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne NE2 4AX, UK.
  • Department of Pharmacology and Therapeutics, Makerere University, Republic of Uganda, Kampala, PO Box 7062.

ORCID-Profile: R Lyus, A M Pollock, P Brhlikova

Zitieren

APA

Green, A., Lyus, R., Ocan, M., Pollock, A. M., & Brhlikova, P. (2023). Registration of essential medicines in Kenya, Tanzania and Uganda: a retrospective analysis. Journal of the Royal Society of Medicine. https://doi.org/10.1177/01410768231181263

Vancouver

Green A, Lyus R, Ocan M, Pollock AM, Brhlikova P. Registration of essential medicines in Kenya, Tanzania and Uganda: a retrospective analysis. Journal of the Royal Society of Medicine. 2023. doi:10.1177/01410768231181263

BibTeX
@article{Green2023,
  author = {Green, A and Lyus, R and Ocan, M and Pollock, A M and Brhlikova, P},
  title = {Registration of essential medicines in Kenya, Tanzania and Uganda: a retrospective analysis},
  journal = {Journal of the Royal Society of Medicine},
  year = {2023},
  doi = {10.1177/01410768231181263}
}
Kostenlos starten →